Yearly Archives: 2016

Home/2016

Loxo Oncology Announces Plans for LOXO-101

In a recent press release, Loxo Oncology announced an update on the status of their TRK (tropomyosin receptor kinase) inhibitor drug, larotrectinib (LOXO-101). Larotrectinib targets the NTRK genes, which encode for the TRK kinases. [...]

By |2020-02-21T15:03:40-05:00December 22nd, 2016|Clinical Trials, News, Research|

7th Annual GIST Group Switzerland Prize Awarded to Professor Abbas Agaimy

Left to Right: Martin Wettstein, Dr. Michael Montemurro, Helga Meier Schnorf, Prof. Abbas Agaimy, Prof. Richard Herrmann GIST Group Switzerland, the support group for patients with gastrointestinal stromal tumor (GIST), has awarded [...]

By |2018-10-30T09:26:20-04:00December 19th, 2016|Global, News, Research|

Seminar for Chilean Patient Organizations Aligns Common Goals

On November 26, 2016, patient advocacy organizations in Chile came together at the School of Medicine at the University of San Sebastian in Santiago, Chile for a seminar entitled "Clinical Studies, Clinical Guidelines and [...]

By |2018-10-30T09:26:28-04:00December 12th, 2016|Advocacy, Events, Global, News|

Help MaKayla Realize Her Dream: Donate to double patient survival

MaKayla Evens help kick off our holiday campaign. MaKayla Evans was diagnosed with Wild Type GIST in 2011, when she was 14 years old. She wanted to speak knowledgeably with her doctors [...]

By |2020-01-31T11:01:40-05:00November 30th, 2016|Fundraising, Member Stories, News, Newsletter|

A Year in Review: 2016 Executive Director’s Report

Norman Scherzer, Executive Director The Life Raft Group at its core is a love story—a love shared between a husband and wife, a mother and daughter, a brother, a sister, parents, grandparents [...]

By |2018-10-30T09:26:46-04:00November 30th, 2016|Executive Director's Report, Newsletter|
Go to Top